{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:26:13Z","timestamp":1778628373180,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41388-018-0235-y","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T11:56:49Z","timestamp":1524571009000},"page":"4046-4054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition"],"prefix":"10.1038","volume":"37","author":[{"given":"Albana","family":"Gattelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn E.","family":"Garc\u00eda Sol\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim C.","family":"Roloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Cardiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith C.","family":"Kordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis A.","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"235_CR1","doi-asserted-by":"publisher","first-page":"a003186","DOI":"10.1101\/cshperspect.a003186","volume":"2","author":"NE Hynes","year":"2010","unstructured":"Hynes NE, Watson CJ. Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb Perspect Biol. 2010;2:a003186.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"235_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","volume":"60","author":"M Grieco","year":"1990","unstructured":"Grieco M, Santoro M, Berlingieri MT, Melilo RM, Donghi R, Bongarzone I, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990;60:557\u201363.","journal-title":"Cell"},{"key":"235_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nm.2644","volume":"18","author":"T Kohno","year":"2012","unstructured":"Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T. et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med. 2012;18:375\u20137.","journal-title":"Nat Med"},{"key":"235_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun. 2014;5:4846.","journal-title":"Nat Commun"},{"key":"235_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534:47\u201354.","journal-title":"Nature"},{"key":"235_CR6","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1158\/0008-5472.CAN-07-5100","volume":"68","author":"A Boulay","year":"2008","unstructured":"Boulay A, Breuleux M, Stephan C, Fux C, Brisken C, Fiche M, et al. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer Res. 2008;68:3743\u201351.","journal-title":"Cancer Res"},{"key":"235_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/emmm.201302625","volume":"5","author":"A Gattelli","year":"2013","unstructured":"Gattelli A, Nalvarte I, Boulay A, Roloff TC, Schreiber M, Carragher N, et al. Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells. EMBO Mol Med. 2013;5:1335\u201350.","journal-title":"EMBO Mol Med"},{"key":"235_CR8","doi-asserted-by":"publisher","first-page":"11732","DOI":"10.1158\/0008-5472.CAN-07-2343","volume":"67","author":"S Esseghir","year":"2007","unstructured":"Esseghir S, Todd SK, Hunt T, Poulsom R, Plaza-Menacho I, Reis-Filho JS, et al. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET\/GFR alpha 1 receptor up-regulation in breast cancer. Cancer Res. 2007;67:11732\u201341.","journal-title":"Cancer Res"},{"key":"235_CR9","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1038\/onc.2010.209","volume":"29","author":"I Plaza-Menacho","year":"2010","unstructured":"Plaza-Menacho I, Morandi A, Robertson D, Pancholi S, Drury S, Dowsett M, et al. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene. 2010;29:4648\u201357.","journal-title":"Oncogene"},{"key":"235_CR10","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-13-2221","volume":"20","author":"PM Spanheimer","year":"2014","unstructured":"Spanheimer PM, Park JM, Askeland RW, Kulak MV, Woodfield GW, De Andrade JP, et al. Inhibition of Ret increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer. Clin Cancer Res. 2014;20:2115\u201325.","journal-title":"Clin Cancer Res"},{"key":"235_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1096\/fj.01-0551com","volume":"16","author":"EJ Gunther","year":"2002","unstructured":"Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, et al. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 2002;16:283\u201392.","journal-title":"FASEB J"},{"key":"235_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1535-6108(02)00212-X","volume":"2","author":"SE Moody","year":"2002","unstructured":"Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, et al. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002;2:451\u201361.","journal-title":"Cancer Cell"},{"key":"235_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ncb1567","volume":"9","author":"JC Sarkisian","year":"2007","unstructured":"Sarkisian JC, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. Dose-dependent oncogene-induced senescence in vivo and its evasion during mamary tumorigenesis. Nat Cell Biol. 2007;9:493\u2013505.","journal-title":"Nat Cell Biol"},{"key":"235_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/gcc.20807","volume":"49","author":"GW Woodfield","year":"2010","unstructured":"Woodfield GW, Chen Y, Bair TB, Domann FE, Weigel J. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chrom Cancer. 2010;49:948\u201362.","journal-title":"Genes Chrom Cancer"},{"key":"235_CR15","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1158\/0008-5472.CAN-12-4265","volume":"73","author":"A Morandi","year":"2013","unstructured":"Morandi A, Martin LA, Gao Q, Pancholi S, Mackay A, Robertson D. et al. GDNF-Ret signalling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors. Cancer Res. 2013;73:3783\u201395.","journal-title":"Cancer Res"},{"key":"235_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/A:1018712905244","volume":"4","author":"RD Cardiff","year":"1999","unstructured":"Cardiff RD, Wellings SR. The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia. 1999;4:105\u201322.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"235_CR17","first-page":"535","volume":"5","author":"T Iwamoto","year":"1990","unstructured":"Iwamoto T, Takahashi M, Ito M, Hamaguchi M, Isobe K, Misawa N, et al. Oncogenicity of the ret transforming gene in MMTV\/ret transgenic mice. Oncogene. 1990;5:535\u201342.","journal-title":"Oncogene"},{"key":"235_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"235_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4161\/jkst.20045","volume":"1","author":"L Avalle","year":"2012","unstructured":"Avalle L, Pensa S, Regis G, Novelli F, Poli V. Stat1 and Stat3 in tumorigenesis. A matter of balance. JAK-STAT. 2012;1:65\u201372.","journal-title":"JAK-STAT"},{"key":"235_CR20","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/bcr3100","volume":"14","author":"SR Chan","year":"2012","unstructured":"Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, et al. Stat1-deficient mice spontaneously develop estrogen receptor a-positive luminal mammary carcinomas. Brest Cancer Res. 2012;14:R16.","journal-title":"Brest Cancer Res"},{"key":"235_CR21","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1200\/JCO.2007.12.2747","volume":"25","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol. 2007;25:4772\u20138.","journal-title":"J Clin Oncol"},{"key":"235_CR22","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1158\/0008-5472.CAN-06-4605","volume":"67","author":"N Akeno-Stuart","year":"2007","unstructured":"Akeno-Stuart N, Croyle M, Knauf JA, Malaguarnera R, Vitagliano D, Santoro M, et al. The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells. Cancer Res. 2007;67:6956\u201364.","journal-title":"Cancer Res"},{"key":"235_CR23","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/cas.12275","volume":"104","author":"T Kohno","year":"2013","unstructured":"Kohno T, Tsuta K, Tsuchihara K, Nakaodu T, Yoh K, Goto K. Ret fusion gene: Translation to personalized lung cancer therapy. Cancer Sci. 2013;104:1396\u20131400.","journal-title":"Cancer Sci"},{"key":"235_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/onc.2011.553","volume":"31","author":"J Kang","year":"2010","unstructured":"Kang J, Qian PX, Pandey V, Perry JK, Miller LD, Liu ET, et al. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene. 2010;31:402.","journal-title":"Oncogene"},{"key":"235_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M, Burris HA, Ruggo HS, Sahmoud T, et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 2012;366:520\u20139.","journal-title":"N Engl J Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0235-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:10Z","timestamp":1684617070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0235-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":25,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0235-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}